Dr. Eng-Yen Huang graduated from the China Medical University in Taiwan. He has a Ph.D. degree in Graduate Institute of Clinical Medical Sciences, Chang Gung University. The current position of Dr. Huang is the professor of Proton and Radiotherapy Center in Kaohsiung Chang Gung Memorial Hospital. The major expertise of Dr. Huang is radiotherapy in gynecological oncology. Dr. Huang has research interests in cervical cancer, which includes radiation-induced bowel complications, translational researches and prognostic factors. He published 37 first or corresponding-author articles in international journals. He published 9 first-author articles in the top journal of Radiation Oncology (IJROBP). He has 3 articles of antioxidant dependent and independent mechanism of radioprotectors to alleviate acute small-bowel damage. He first found that galectin-1, SCC-Ag, and CEA are very important factors for the recurrence following definitive pelvis radiotherapy. Efforts to improve the treatment outcome is further planned by translational studies.
Short Biography
Dr. Eng-Yen Huang graduated from the China Medical University in Taiwan. He has a Ph.D. degree in Graduate Institute of Clinical Medical Sciences, Chang Gung University. The current position of Dr. Huang is the professor of Proton and Radiotherapy Center in Kaohsiung Chang Gung Memorial Hospital. The major expertise of Dr. Huang is radiotherapy in gynecological oncology. Dr. Huang has research interests in cervical cancer, which includes radiation-induced bowel complications, translational researches and prognostic factors. He published 37 first or corresponding-author articles in international journals. He published 9 first-author articles in the top journal of Radiation Oncology (IJROBP). He has 3 articles of antioxidant dependent and independent mechanism of radioprotectors to alleviate acute small-bowel damage. He first found that galectin-1, SCC-Ag, and CEA are very important factors for the recurrence following definitive pelvis radiotherapy. Efforts to improve the treatment outcome is further planned by translational studies.
